Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cisplatin 268Oxaliplatin 195Carboplatin 189Capecitabine 184Docetaxel 177apatinib 164Paclitaxel 159Bevacizumab 157Gemcitabine 155Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 124Irinotecan 120Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 76Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Unknown × SKLB1028 × Clear all
NCT04015024 2019-07-16

A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 2 Unknown
30 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡